» Articles » PMID: 39863303

Trends in Work Participation Among Patients with Inflammatory Rheumatic Musculoskeletal Diseases (iRMDs): Data from the German National Database (2010-2022)

Overview
Journal RMD Open
Date 2025 Jan 25
PMID 39863303
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To analyse work participation among patients with inflammatory rheumatic musculoskeletal diseases (iRMDs), namely rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc) and ANCA-associated vasculitis (AAV).

Methods: A cross-sectional sample of 16 421 patients from the National Database of the German Collaborative Arthritis Centers, aged <65 years were analysed. For each diagnosis, yearly rates of absenteeism, employment and disability pensions were analysed from 2010 to 2022. Population data were used to calculate standardised employment ratios (SERs), adjusted for age, sex, federal state and vocational qualification. The analysis was additionally stratified by sex, adjusting for other factors.

Results: Over the observed time span, large employment increases were found across all diagnoses, namely in RA (54%-68%), PsA (58%-72%), SSc (47%-66%), AAV (43%-61%), SLE (48%-60%) and axSpA (65%-73%). SERs were for RA 0.88 (95% CI 0.86 to 0.90), axSpA (0.88 (0.84 to 0.91)), PsA (0.88 (0.85 to 0.91)), SSc (0.83 (0.75 to 0.91)), SLE (0.76 (0.72 to 0.80)) and AAV (0.73 (0.63 to 0.83)). In RA, axSpA, PsA and AAV, SERs were higher in men while in SLE and SSc men had lower SER. Median of yearly absenteeism due to the disease decreased by 5 (RA), 1 (axSpA), 6 (PsA), 11 (SLE), 4 (SSc) and 10 days (AAV) in the time span. Except for SSc, the proportion of disability pension receivers decreased for all diagnoses.

Conclusion: Since 2010, work participation has improved for patients with iRMDs, as reflected in higher employment, reduced absenteeism and less disability retirement. However, patients have not reached population employment rates.

References
1.
Boonen A, Webers C, Butink M, Barten B, Betteridge N, Black D . 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work. Ann Rheum Dis. 2022; 82(1):57-64. DOI: 10.1136/ard-2022-222678. View

2.
De Craemer A, Deroo L, Renson T, Desimpele I, Delmez L, Decuman S . Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT. Rheumatology (Oxford). 2022; 62(5):1841-1850. DOI: 10.1093/rheumatology/keac529. View

3.
Putrik P, Ramiro S, Guillemin F, Pentek M, Sivera F, Sokka T . Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries. Ann Rheum Dis. 2019; 78(11):1472-1479. DOI: 10.1136/annrheumdis-2019-215294. View

4.
Mau W, Listing J, Huscher D, Zeidler H, Zink A . Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol. 2005; 32(4):721-8. View

5.
Rudwaleit M, Morup M, Humphries B, Zannat N, Willems D, Taieb V . Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis. RMD Open. 2023; 9(4). PMC: 10689353. DOI: 10.1136/rmdopen-2023-003468. View